Dystrophin nonsense mutations can generate alternative rescue transcripts in lymphocytes

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Secondary splicing alterations can produce semi-functional mRNA from nonsense mutations in the dystrophin gene.
• Disruptions of exonic splicing enhancers by single nucleotide changes are implicated in these alterations.
• The exact frequency of these mutation-dependent splicing alterations is currently unknown.

Purpose of the Study:

• To investigate the frequency and patterns of dystrophin mRNA splicing alterations in patients with nonsense mutations.
• To explore the underlying mechanisms and identify potential therapeutic targets for dystrophinopathies.

Main Methods:

• Analysis of dystrophin mRNA splicing patterns in lymphocytes from 38 patients with dystrophinopathies due to nonsense mutations.
• Examination of cis-regulatory splicing elements, including splicing probability scores and potential enhancer/silencer sequences.
• Correlation of splicing patterns with clinical presentation.

Main Results:

• Partial skipping of the nonsense-encoding exon was observed in 18% (7/38) of patients.
• Two cases showed complex splice site activation, generating novel transcripts.
• No single cause for exon skipping was identified through analysis of cis-regulatory elements; individual differences were noted even with identical mutations (C.5899C>T).

Conclusions:

• Dystrophinopathies exhibit diverse splicing alterations in response to nonsense mutations, with significant individual variability.
• The findings highlight potential targets for therapeutic strategies like antisense oligonucleotide-induced exon skipping and ribosomal read-through.
• Further research is needed to fully elucidate the mechanisms governing these splicing alterations and their clinical impact.